Skip to main content
OpenTrials
Completed

NCT Number: NCT06622096

Evaluation of Lab Exams Accuracy in the Intensive Care Unit

prospective, observational descriptive study assessing the accuracy of laboratory exams in the ICU.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mongi Slim University Hospital

Tunis, Tunis Governorate, 2046, Tunisia

About this study

Laboratory exams prescription for ICU patients was evaluated daily and their accuracy was determined according to locally implemented prescription protocol and to their abnormalities and the impact on further therapeutics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All adults ICU patients with a length of stay>24 hours

Exclusion criteria

  • Patients transferred from other ICUs
  • Currently unavailable laboratory tests

Treatment and study plan

Evaluation of laboratory exams prescription

Diagnostic Test

Evaluation of laboratory exams prescription

Primary outcomes

  1. Blood loss due to laboratory tests

    Time frame: 7 days

    evolution of hemoglobin levels before and after laboratory tests

Sponsors and collaborators

Lead sponsor

Mongi Slim Hospital

Other

Registry information

Official study title

Rationalization of Laboratory Tests in the ICU: Current State of Play

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 1, 2024
Registry last updated
Oct 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.